Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/29/2005WO2005067692A3 Detection and quantification of analytes in solution using polymers
09/29/2005WO2005063807A3 Treatment of coronary or peripheral ischemia
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005058021A3 Generation of plants with altered oil content
09/29/2005WO2005056807A3 Bovine adeno-associated viral (baav) vector and uses thereof
09/29/2005WO2005056757A3 A method for the positive selection of chromosomal mutations in c1 metabolizing bacteria via homologous recombination
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005052169A3 Plant disease resistance and sar regulator protein
09/29/2005WO2005046732A3 Methods and compositions for the inhibition of hiv-1 replication
09/29/2005WO2005046616A3 Viral propagation system and uses thereof
09/29/2005WO2005042741A3 Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions
09/29/2005WO2005040336A3 Dna cloning vector plasmids and methods for their use
09/29/2005WO2005039642A9 Dna delivery with gemini cationic surfactants
09/29/2005WO2005038005A9 Shc proteins as therapeutic targets in proliferative diseases
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2005019428B1 Regulation of polynucleic acid activity and expression
09/29/2005WO2005014787A3 Genetic elements conferring flower petal-specific transgene expression
09/29/2005WO2005012360A3 Binding molecules against sars-coronavirus and uses thereof
09/29/2005WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
09/29/2005WO2004108939A8 Bav packaging regions and e1 transcriptional control regions
09/29/2005WO2004092338A3 Compositions, splice variants and methods relating to cancer specific genes and proteins
09/29/2005WO2004089302A3 Posh polypeptides, complexes and related methods
09/29/2005WO2004085618A3 Method of screening for target ligands
09/29/2005WO2004073609A3 Posh associated kinases and related methods
09/29/2005WO2004070008A8 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
09/29/2005WO2004035760A3 Complete biosynthetic gene set for biosynthesis of albicidin, resistance genes, and uses thereof
09/29/2005WO2004014314A3 Methods and compositions concerning poxviruses and cancer
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005WO2003046186A8 siRNA EXPRESSION SYSTEM AND METHOD FOR PRODUCING FUNCTIONAL GENE KNOCK-DOWN CELLS USING THE SYSTEM
09/29/2005WO2002079491A3 Method for correlating gene expression profiles with protein expression profiles
09/29/2005US20050216976 Chimeric sequences for tissue-specific gene expression in plants
09/29/2005US20050216975 Nucleotide sequences coding oxidoreductase for use in transfer, expression and production of omega-3 and omega-6 fatty acids in yarrowia
09/29/2005US20050216974 Plant reproduction polynucleotides and methods of use
09/29/2005US20050216973 Plant vitamin E biosynthetic enzymes
09/29/2005US20050216972 Cotton cultivar DP 611 BGII/RR
09/29/2005US20050216971 DNA having a nucleotide sequence encoding insecticidal proteins; chimeric genes and host cells and plants containing them
09/29/2005US20050216970 Corn event MIR604
09/29/2005US20050216969 Insect resistant cotton seed: transformation events of cotton plants with one or more polynucleotide sequences inserted into specific site(s) within the genome of a cotton cell
09/29/2005US20050216968 Nucleotide sequences coding fertilization-independent endosperm polypeptide for use in controlling endosperm development in flowering plants
09/29/2005US20050216967 Expression cassettes for transgenic expression of nucleic acids
09/29/2005US20050216963 Prion-free transgenic ungulates
09/29/2005US20050216962 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
09/29/2005US20050216961 Cancer associated protein kinases and their uses
09/29/2005US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response
09/29/2005US20050216959 Using biobolistic electric discharge particle acceleration to transfer gold coated beads into cells; improving heterologous gene transfer and expression
09/29/2005US20050216201 Techniques for synthesis integrity evaluation utilizing cycle fidelity probes
09/29/2005US20050215777 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer; one pot deprotection; solution phase synthesis; solid phase synthesis
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215619 Pure culture of Pseudomonas putida TX2 (BCRC 910232) with capacity to grow on alkylphenol polyethoxylates or alkylphenols as sole source of carbon and energy; bioremediation of these nonionic surfactants
09/29/2005US20050215509 Method for inhibiting jnk-1 kinase activity by SCCA
09/29/2005US20050215507 Therapeutic anti-cancer DNA
09/29/2005US20050215506 Antisense nucleotide sequences for inhibiting the expression of tyrosinase; control melanin biosynthetic pathway; treating pigment disorder of eyes, hair, and skin, and melanoma
09/29/2005US20050215505 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
09/29/2005US20050215504 Antisense modulation of sterol regulatory element-binding protein-1 expression
09/29/2005US20050215503 HIF oligonucleotide decoy molecules
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215499 Lipoproteins as nucleic acid vectors
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215490 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050215474 inducing a specific immune response to DNA vaccines; as an adjuvant, immunostimulants
09/29/2005US20050215467 Multimeric Apo A-I agonist compounds
09/29/2005US20050214946 Electrolytic cells; positioning electrodes; sealing caps which are color codes
09/29/2005US20050214945 Htlv-I tax induced killing of p53 null cancer cells
09/29/2005US20050214944 Using single-stranded nucleic acids and homologus recombination to correct defects in tumor suppressor genes; treating and preventing cell proliferative disorders; gene therapy
09/29/2005US20050214932 Apparatus and chip for injecting substance into particle
09/29/2005US20050214926 Adhering nucleotide sequences to solid support; gene expression analysis
09/29/2005US20050214923 Recombinant viral vector comprising antitumor agents for use in targeted tissue therapy; gene therapy
09/29/2005US20050214922 Alkaline protease
09/29/2005US20050214921 BGL3 beta-glucosidase and nucleic acids encoding the same
09/29/2005US20050214920 Detergent composition containing the polypeptide and a surfactant; can be used in the conversion of cellulosic materials to monosaccharides, disaccharides, and polysaccharides
09/29/2005US20050214919 Novel lipase genes
09/29/2005US20050214917 Thermo-stable lactate oxidase
09/29/2005US20050214915 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
09/29/2005US20050214913 Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes
09/29/2005US20050214912 Using transgenic escherichia, comprising hydantoinase and carbamoylase genes, as bioreactor for fermentation of histidine for use in foods and drugs
09/29/2005US20050214911 Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214909 Genes from a gene cluster
09/29/2005US20050214906 Means and methods for regulating gene expression
09/29/2005US20050214905 Novel compounds
09/29/2005US20050214904 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
09/29/2005US20050214903 O-superfamily conotoxin peptides
09/29/2005US20050214901 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
09/29/2005US20050214900 Enzyme/tag binding and detection system
09/29/2005US20050214899 Capable of removing the N-terminal Met from bulky or acidic penultimate residues
09/29/2005US20050214886 Using intracellular domain of tumor necrosis factor as screening tool in detection of modulators for treatment of inflammation, sepsis, rheumatic and eating disorders
09/29/2005US20050214883 Novel alanine transaminase enzyme and methods of use
09/29/2005US20050214879 Novel ubiquitin ligases as therapeutic targets
09/29/2005US20050214867 Prion protein standard and method of making same
09/29/2005US20050214861 Human hematopoietic stem and progenitor antigen and methods for its use
09/29/2005US20050214858 Nucleotide sequences coding liver protein for identifying modulators for prevention and treatment diabetes
09/29/2005US20050214857 Method for displaying loops from immunoglobulin domains in different contexts
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050214851 Linearized vector for heterologus gene transfer, control and expression
09/29/2005US20050214850 Sitosterolemia susceptibility gene (SSG): compositions and methods of use
09/29/2005US20050214849 DNA sequencing method
09/29/2005US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 ... 4023